Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Opinion & Editorial
July 06, 2021 05:00 AM

Dueling opinions: What about drug prices in America?

Modern Healthcare
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Dan Jones and Lori Reilly

    Dan Jones, vice president of federal affairs at the Alliance of Community Health Plans

    Lori Reilly, chief operating officer at the Pharmaceutical Research and Manufacturers of America

    According to a 2021 RAND Corp. study, drug prices on average in the U.S. are 2.5 times those paid by 32 other nations in the Organisation for Economic Co-Operation and Development.

    What’s the best approach to balancing incentives for pharma research and development with the drug affordability challenges we’ve had for decades?

    Dan Jones: I’ll throw the question back at you. At what level are they making R&D investments? We support innovation and market forces. We want to see new drugs to help cure diseases and illnesses. But the pricing aspect to some of the drugs that come to market in many respects is untethered and unjustified and the efficacy is questionable. And there’s just no transparency.

    Lori Reilly: If you look out over the past decade, prices for prescription drugs have been at or below the rate of inflation. In 2020, net prices were a negative growth rate. That’s in part because of the competition we have in our system. Nearly 90% of all prescriptions are generic. So we have, in our opinion, a system that’s by and large working.

    What are some steps insurers and health plans can take to reduce members’ drug costs?

    Jones: In many ways, the health plan role is within a market that works, where we can negotiate good drug prices, where we’ve entered value-based arrangements. But we’re reminded how many ways the market has failed, whether it’s anti-competitive type practices by some drugmakers manipulating the market, keeping competition at bay, or hiking prices of old drugs without much justification.

    Reilly: One place to start is the rebate system. If you look at the list price of a branded medication, about half the total price goes to someone other than the manufacturer. It’s going to the pharmacy benefit manager, the insurer and other pieces of the supply chain, maybe hospitals and others. You can make a big dent in lowering what patients pay by reforming the rebate system.

    Where does your organization stand on giving authority to HHS/Medicare to negotiate with drugmakers on drugs that don’t have any competition?

    Jones: We’ve laid out a set of reforms we believe need to be addressed together. The (HHS) secretarial negotiation is a piece of it. What has drawn a lot of support is reforming the Part D benefit in a way to create an out-of-pocket cap for catastrophic costs. … Drugs with prices that are rising faster than the rate of inflation also should be addressed.

    Reilly: That’s an issue that has come up many times since passage of the Medicare Part D benefit. What people maybe fail to appreciate regarding Part D is there’s already negotiation occurring. … I think what the question actually means is do we want the government to insert itself and make a decision about what choice and access to medicines a patient may get.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Dennis Matheis
    Sentara Healthcare names Dennis Matheis next top executive
    supreme-court-healthcare-ok_WEB_i.jpg
    Healthcare groups react to Supreme Court abortion ruling
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing